ArticleACS medicinal chemistry letters2022

Discovery of TAK-925 as a Potent, Selective, and Brain-Penetrant Orexin 2 Receptor Agonist.

Tatsuhiko Fujimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.